Skip to main content
. 2019 Dec 11;20(24):6238. doi: 10.3390/ijms20246238

Table 1.

Statistical testing of data in Figure 6 indicates significant differences in mouse spinal cord x neuroblastoma hybrid (NSC-34) cell sensitivity to arginine-rich dipeptide repeat proteins (DRPs) with increasing differentiation 1.

DRP Endpoint 3 µM 1 µM 300 nM 100 nM 30 nM 10 nM
Day 14 **** ns **** **** **** ****
GR15 Day 21 **** **** **** **** **** ****
Day 28 **** **** **** **** **** ****
Day 14 ** ns **** **** *** ****
PR15 Day 21 **** **** **** **** **** ****
Day 28 **** **** **** **** **** ****
Day 14 ns ns ns ns *** ns
PA15 Day 21 ns ns ns ns ** ns
Day 28 ns ns ns ns **** ns
Day 14 ns ns ns * ns ns
GP15 Day 21 ns ns ns ns ns ns
Day 28 ns * ns * ns ns

1 * denotes p < 0.05, ** denotes p < 0.01, *** denotes p < 0.001, and **** denotes p < 0.0001 comparing changes in WST-1 absorbance at each differentiation endpoint (day 14, day 21, day 28) to values at day 7 endpoint by two-way ANOVA analysis of variance followed by Dunnett’s test.